Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-01-05 @ 3:28 AM
Study NCT ID:
NCT00993668
Status:
COMPLETED
Last Update Posted:
2018-08-01
First Post:
2009-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines
Sponsor:
UCB Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-09
First Submit QC Date:
None
Study First Post Date:
2009-10-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-23
Results First Submit QC Date:
None
Results First Post Date:
2011-06-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-04
Last Update Post Date:
2018-08-01
Last Update Post Date Type:
ACTUAL